Regeneron Pharmaceuticals' Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Regeneron Pharmaceuticals careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Rege...
Posted: June 19, 2019, 8:20 am
Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Rege...
Posted: June 19, 2019, 8:20 am
Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Rege...
Posted: June 19, 2019, 8:20 am
Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Rege...
Posted: June 19, 2019, 8:20 am
Regeneron offers a unique, world-class opportunity for interested candidates. Regeneron has been consistently ranked a “Top Employer” in Science Magazine’s rankings for pharmaceutical and biotechnology companies. Regeneron is fully committed to br...
Posted: June 19, 2019, 8:20 am

Viewing page 1 of 100|Next Page

  Newsfeed | Subscribe  

Farnier reports research support from Sanofi/Regeneron, Pfizer, Amgen, Merck, Eli Lilly, AstraZeneca, Kowa Pharmaceuticals, Amarin, Servier, and Daiichi-Sankyo. He reports speaker fees from ...
Posted: June 19, 2019, 12:04 am
Argus Research analysts Jasper Hellweg and Kelly Hannigan see threats to Reneron Pharmaceuticals' (REGN ... in the U.S., and 2024 in Europe. Though Regeneron has a strong pipeline and new ...
Posted: June 18, 2019, 7:38 am
The study will be presented at a future medical conference. Additionally, drugmakers such as Regeneron Pharmaceuticals Inc and Johnson & Johnson have abandoned certain programs to find a treatment ...
Posted: June 17, 2019, 9:35 am
Regeneron Pharmaceuticals, Inc. REGN announced positive early-stage data for pipeline candidate, REGN1979. The data will be presented at the 24th Congress of the European Hematology Association (EHA). ...
Posted: June 17, 2019, 7:05 am
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets ...
Posted: June 14, 2019, 5:19 pm

Viewing page 1 of 3|Next Page